Clinical Trial Details
| Trial ID: | L5582 |
| Source ID: | NCT05928637 |
| Associated Drug: | D745, D759, D150 |
| Title: | A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150 |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Diabetes type2 |
| Interventions: | DRUG: D745, D759, D150 |
| Outcome Measures: | Primary: AUCt, Area under the concentration-time curve time zero to time, [0d, 12d, 24d] pre-dose, [2d, 14d, 26d] pre-dose, [3d, 15d, 27d] pre-dose, [4d, 16d, 28d] pre-dose, and 0.33, 0.67, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 7, 8, 10, 12h, [5d, 17d, 29d] 24h|Cmax, Maximum plasma concentration of the drug, [0d, 12d, 24d] pre-dose, [2d, 14d, 26d] pre-dose, [3d, 15d, 27d] pre-dose, [4d, 16d, 28d] pre-dose, and 0.33, 0.67, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 7, 8, 10, 12h, [5d, 17d, 29d] 24h | |
| Sponsor/Collaborators: | Sponsor: Chong Kun Dang Pharmaceutical |
| Gender: | ALL |
| Age: | ADULT |
| Phases: | PHASE1 |
| Enrollment: | 24 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT |
| Start Date: | 2023-07-10 |
| Completion Date: | 2023-09-05 |
| Results First Posted: | |
| Last Update Posted: | 2024-03-12 |
| Locations: | Catholic Hospital, Seoul, Seoul, Korea, Republic of |
| URL: | https://clinicaltrials.gov/show/NCT05928637 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|